AIG vs COYA · P/E 21, rev $13.73B vs rev $7.9M
American International Group Inc (AIG) versus Coya Therapeutics, Inc. Common Stock (COYA) — a side-by-side from cached financials, not a winner call.
American International Group Inc (AIG) is a insurance - diversified company listed on US.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Latest reported AIG revenue for 2026-06-30 was $13.73B. Net income was $1.71B. AIG currently screens at market cap $48.97B and trailing P/E 20.6.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
AIG currently screens at market cap $48.97B and trailing P/E 20.6. COYA currently screens at market cap $118.0M.
Not investment advice. Open the AIG and COYA stock pages for the full models.
Not investment advice.